‘There are no serious safeguards’: can 23andMe be trusted with our DNA?
The at-home genetic testing company is dealing with financial woes and a data breach. What does that mean for customers?
The Guardian - US ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
EXPLAINED: 3 | Vintage Vibes
23andMe's "minimum wage" billionaire
UPDATED: Data-hoarding billionaires don't go to jail — but if they violate our privacy, they can go broke
Salon ·
The human genome revealed its secrets 20 years ago. It’s time to fulfill its promise of personalized health care
Genetics have the potential to transform how we predict, prevent, and treat almost all human disease, writes 23andMe CEO Anne Wojcicki.
Fortune ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
3 Healthtech Stocks Wall Street Predicts Will Rally More Than 40% or More: GoodRx, 23andMe, and Exact Sciences
The COVID-19 pandemic has accelerated digital adoption in healthcare. And because this trend is attracting massive investments into digital health care, Wall Street analysts expect popular health tech stocks Exact Sciences Corp (EXAS), GoodRx Holdings (GDRX), 23andMe (ME) to rally in price soon. Read on.
StockNews.com ·
Coverage From
Fortune
The Independent UK
The Guardian - US
International Business Times
Evening Standard
The Conversation
International Business Times UK
The Guardian - UK
Al Jazeera
Barchart
Bored Panda
Euronews
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
